Alliance for Clinical Trials in Oncology phase I/II study reveals increased progression-free survival for patients

Early results from an Alliance for Clinical Trials in Oncology randomized clinical trial of adults with multiple myeloma relapsing on frontline

Related Keywords

United States ,Charlotte ,North Carolina ,Boston ,Massachusetts ,Dana Farber Cancer Institute ,American ,Paul Richardson ,Peter Voorhees ,Bristol Myers Squibb ,National Clinical Trials Network ,National Cancer Institute ,Alliance For Clinical Trials In Oncology ,Celgene Corporation ,Jerome Lipper Multiple Myeloma Center ,Drug Administration ,Millennium Pharmaceuticals ,Atrium Health In Charlotte ,Directory Of Clinical Research ,A Takeda Oncology Company ,American Cancer Society ,Clinical Program Leader ,Clinical Trials ,Safety Monitoring Board ,Plasma Cell Disorders Division ,Levine Cancer Institute ,Atrium Health ,Clinical Trials Network ,Takeda Oncology Company ,Committee Chair Paul Richardson ,Clinical Research ,Cancer Institute ,